experspadmin

Imaging and Nonimaging Biomarkers in Multiple Sclerosis
Neurology

Imaging and Nonimaging Biomarkers in Multiple Sclerosis

clinical topic updates
By Robert A. Bermel, MD, MBA
Newer Disease-Modifying Therapies for Relapsing Forms of Multiple Sclerosis
Neurology

Newer Disease-Modifying Therapies for Relapsing Forms of Multiple Sclerosis

clinical topic updates
By Malcolm H. Gottesman, MD
Survival in Older Patients With Chronic Lymphocytic Leukemia: Treatment and Nontreatment Factors
Oncology

Survival in Older Patients With Chronic Lymphocytic Leukemia: Treatment and Nontreatment Factors

expert roundtables
By Matthew S. Davids, MD, MMSc
Emerging Standards in the Frontline Treatment of Chronic Lymphocytic Leukemia
Oncology

Emerging Standards in the Frontline Treatment of Chronic Lymphocytic Leukemia

expert roundtables
By Matthew S. Davids, MD, MMSc
Chronic Lymphocytic Leukemia: Geriatric Assessment and Support During Treatment
Oncology

Chronic Lymphocytic Leukemia: Geriatric Assessment and Support During Treatment

patient care perspectives
Load More